• 1
    Woude FJ, Lobatto S, Permin H et al. Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:4259.
  • 2
    Falk RJ & Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:16517.
  • 3
    Duerr RH, Targan SR, Landers CJ et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100:138591.
  • 4
    Oudkerk-Pool M, Ellerbroek PM, Ridwan BU et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993; 34:4660.
  • 5
    Mulder AHL, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17:4117.
  • 6
    Hardarson S, LaBrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993; 99:27781.
  • 7
    Targan S, Landers C, Vidrich A, Czaja AL. High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 1995; 108:115966.
  • 8
    Bansi DS, Fleming KA, Chapman RW. Antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gastroenterology 1995; 109:204955.
  • 9
    Zauli D, Ghetti S, Grassi A et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997; 25:11057.
  • 10
    Walmsley RS, Zhao MH, Hamilton MI et al. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997; 40:1059.
  • 11
    Roozendaal C, Zhao MH, Horst G et al. Catalase and α-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol 1998; 112:106.DOI: 10.1046/j.1365-2249.1998.00528.x
  • 12
    Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Büschenfelde KH, Mayet WJ. Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998; 112:50715.
  • 13
    Halbwachs-Mecarelli L, Nusbaum P, Noel LH et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90:7994.
  • 14
    Peen E, Almer S, Bodemar G et al. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 1993; 34:5662.
  • 15
    Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:20210.
  • 16
    Savige J, Gillis D, Benson E et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999; 111:50713.
  • 17
    Rump JA, Schölmerich J, Gross V et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990; 181:40613.
  • 18
    Terjung B, Herzog V, Worman HJ et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 1998; 28:33240.
  • 19
    Terjung B, Spengler U, Sauerbruch T, Worman HJ. ‘Atypical p-ANCA’ in IBD and hepatobiliary disorders react with a 50 kD nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119:31022.
  • 20
    Billing P, Tahir S, Calfin B et al. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995; 147:97987.
  • 21
    Sobajima J, Ozaki S, Uesugi H et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44:86773.
  • 22
    Mallolas J, Esteve M, Rius E, Cabré E, Gassull MA. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut 2000; 47:748.DOI: 10.1136/gut.47.1.74
  • 23
    Eggena M, Cohavy O, Parseghian MP et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody p-ANCA. J Autoimmun 2000; 14:8397.
  • 24
    Martin L, Herr JC, Wanamaker W, Kornguth S. Demonstration of specific antineuronal nuclear antibodies in sera of patients with myasthenia gravis. Indirect and direct immunofluorescence. Neurology 1974; 24:6803.
  • 25
    Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (Suppl. 6):123.
  • 26
    Cance WG, Chaudhary N, Worman HJ, Blobel G, Cordon-Cando C. Expression of the nuclear lamins in normal and neoplastic human tissues. J Exp Clin Cancer Res 1992; 11:23346.
  • 27
    Spickett GP & Broomhead V. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Pathol 1995; 48:8990.
  • 28
    Fricker M, Hollinshead M, White N, Vaux D. Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol 1997; 136:53144.
  • 29
    Lock RJ. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994; 47:48.
  • 30
    Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel diseases: characterization and clinical correlates. Clin Exp Immunol 1994; 95:4907.
  • 31
    Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Antineutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992; 33:66874.
  • 32
    Chowdhury SM, Broomhead V, Spickett GP, Wilkinson R. Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J Clin Pathol 1999; 52:4757.
  • 33
    Lee SS, Lawton JWM, Chak W. Distinction between antinuclear antibody and p-ANCA. J Clin Pathol 1991; 44:9623.
  • 34
    Bird AG. Is there life in the formalin fixed neutrophil for ANCA testing? No! J Clin Pathol 1999; 52:4034.